All In MedTech

FDA Clearance Tracker · P180028

HeartStart FRx Defibrillator

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: May 11, 2020 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P180028
Device name
HeartStart FRx Defibrillator
Applicant location
Bothell, WA
Received
Aug 3, 2018
Decided
May 11, 2020
Decision
Approved
Supplements
19 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

Approval for the HeartStart FRx Defibrillator (Model 861304). The device is indicated for use on potential victims of sudden cardiac arrest (SCA) with the following symptoms:1) Unconsciousness; and2) Absence of normal breathingThe HeartStart FRx (Model 861304) is indicated for adults over 55 pounds (25 kg). The Model 861304 is also indicated for infants and children under 55 pounds (25 kg) or 0-8 years old when used with the optional Infant/Child Key (Model 989803139311). If the Infant/Child Key is not available, or you are uncertain of the child’s age or weight, proceed using adult treatment without the infant/child key.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MKJ. The earliest in FDA's data is K853564, decided Oct 11, 1985.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Philips Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.